Journal article
Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or Both
Abstract
Although various neurohormones at initial measurement confer prognostic value in heart failure and correlate with the left ventricular ejection fraction (EF) and cardiac volumes, the significance of their temporal changes (Delta) remains undetermined. This study examined temporal changes in neurohormones related to cardiac remodeling and prognosis in patients with systolic dysfunction and heart failure receiving therapeutic inhibition of the …
Authors
Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J
Journal
The American Journal of Cardiology, Vol. 96, No. 5, pp. 698–704
Publisher
Elsevier
Publication Date
September 2005
DOI
10.1016/j.amjcard.2005.04.048
ISSN
0002-9149
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsBenzimidazolesBiomarkersBiphenyl CompoundsCardiac OutputChromatography, High Pressure LiquidDouble-Blind MethodDrug Therapy, CombinationEnalaprilFemaleHeart FailureHumansMaleMiddle AgedNeurotransmitter AgentsPrognosisSystoleTetrazolesTreatment OutcomeVentricular Dysfunction, LeftVentricular Remodeling